Argent Trust Co’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$25.2M Sell
27,417
-215
-0.8% -$218K 0.86% 23
2025
Q4
$29.7M Sell
27,632
-279
-1% -$267K 1.02% 19
2025
Q3
$21.3M Sell
27,911
-242
-0.9% -$180K 0.75% 28
2025
Q2
$21.9M Buy
28,153
+3,315
+13% +$2.58M 0.83% 28
2025
Q1
$20.5M Buy
24,838
+303
+1% +$252K 0.84% 27
2024
Q4
$18.9M Buy
24,535
+479
+2% +$397K 0.77% 27
2024
Q3
$21.3M Buy
24,056
+709
+3% +$637K 0.88% 24
2024
Q2
$21.1M Sell
23,347
-608
-3% -$486K 0.93% 22
2024
Q1
$18.6M Buy
23,955
+997
+4% +$710K 0.84% 23
2023
Q4
$13.4M Buy
22,958
+839
+4% +$490K 0.67% 35
2023
Q3
$11.9M Buy
22,119
+367
+2% +$189K 0.65% 34
2023
Q2
$10.2M Buy
21,752
+503
+2% +$211K 0.55% 43
2023
Q1
$7.3M Buy
21,249
+2,536
+14% +$855K 0.46% 55
2022
Q4
$6.85M Buy
18,713
+31
+0.2% +$11K 0.45% 62
2022
Q3
$6.04M Sell
18,682
-985
-5% -$312K 0.44% 64
2022
Q2
$6.38M Buy
19,667
+1,657
+9% +$497K 0.44% 62
2022
Q1
$5.16M Sell
18,010
-560
-3% -$144K 0.31% 74
2021
Q4
$5.13M Buy
18,570
+447
+2% +$113K 0.3% 77
2021
Q3
$4.19M Buy
18,123
+154
+0.9% +$38K 0.27% 90
2021
Q2
$4.13M Buy
17,969
+107
+0.6% +$21.5K 0.27% 91
2021
Q1
$3.34M Buy
17,862
+967
+6% +$189K 0.23% 98
2020
Q4
$2.85M Buy
16,895
+1,194
+8% +$178K 0.22% 101
2020
Q3
$2.32M Sell
15,701
-326
-2% -$50.5K 0.2% 108
2020
Q2
$2.63M Buy
16,027
+2,139
+15% +$328K 0.25% 94
2020
Q1
$1.93M Buy
13,888
+1,538
+12% +$211K 0.22% 109
2019
Q4
$1.62M Buy
12,350
+990
+9% +$115K 0.14% 148
2019
Q3
$1.27M Sell
11,360
-7
-0.1% -$779 0.12% 160
2019
Q2
$1.26M Buy
11,367
+296
+3% +$34.9K 0.13% 160
2019
Q1
$1.44M Buy
11,071
+3,404
+44% +$414K 0.15% 149
2018
Q4
$887K Sell
7,667
-331
-4% -$37K 0.1% 190
2018
Q3
$850K Hold
7,998
0.1% 188
2018
Q2
$682K Buy
7,998
+4,121
+106% +$338K 0.08% 214
2018
Q1
$300K Buy
3,877
+507
+15% +$40.8K 0.09% 218
2017
Q4
$285K Sell
3,370
-298
-8% -$25.4K 0.11% 202
2017
Q3
$314K Sell
3,668
-41
-1% -$3.36K 0.12% 194
2017
Q2
$305K Sell
3,709
-460
-11% -$37.5K 0.13% 205
2017
Q1
$350K Buy
4,169
+10
+0.2% +$801 0.14% 189
2016
Q4
$306K Sell
4,159
-834
-17% -$62.1K 0.14% 195
2016
Q3
$401K Buy
4,993
+809
+19% +$64.8K 0.17% 170
2016
Q2
$329K Buy
4,184
+12
+0.3% +$903 0.14% 186
2016
Q1
$300K Buy
4,172
+269
+7% +$20.4K 0.15% 188
2015
Q4
$329K Buy
3,903
+397
+11% +$32.9K 0.16% 171
2015
Q3
$293K Sell
3,506
-650
-16% -$54.9K 0.17% 168
2015
Q2
$347K Buy
4,156
+250
+6% +$19K 0.17% 168
2015
Q1
$284K Buy
3,906
+389
+11% +$27.7K 0.14% 190
2014
Q4
$243K Buy
+3,517
New +$237K 0.15% 182

Other funds holding LLY

Argent Trust Co's LLY Position: Q1 2026 in Review

Argent Trust Co reduced its Eli Lilly (LLY) stake by 0.78% in Q1 2026, selling an estimated $218K and leaving 27,417 shares worth $25.2M. The position accounts for 0.86% of the portfolio, ranked #23.

Argent Trust Co first reported a position in LLY in Q4 2014 and has held it in 46 quarters since. The position peaked at $29.7M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Argent Trust Co held 27,417 shares of Eli Lilly worth $25.2M as of Q1 2026.
  • Argent Trust Co sold 215 Eli Lilly shares in Q1 2026, an estimated $218K.
  • Eli Lilly made up 0.86% of Argent Trust Co's portfolio in Q1 2026, its #23 holding.
  • Argent Trust Co first reported a position in Eli Lilly in Q4 2014 and has held it in 46 quarters since.
  • Argent Trust Co's Eli Lilly position peaked at $29.7M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Argent Trust Co's 13F filing for Q1 2026, filed 13 May 2026.